title: [Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
authors.forename: Towako
authors.initials: T
authors.lastname: Nagata
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mukae
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Kadokawa
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Kaida
authors.forename: Misuzu
authors.initials: M
authors.lastname: Kuroki
authors.forename: Katsunori
authors.initials: K
authors.lastname: Yanagihara
authors.forename: Kazunori
authors.initials: K
authors.lastname: Asano
authors.forename: Jyunichi
authors.initials: J
authors.lastname: Kadota
authors.forename: Takehiko
authors.initials: T
authors.lastname: Koji
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kawano
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D018441:Biofilms / Q000254:growth & development*; D002908:Chronic Disease; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004917:Erythromycin / Q000008:administration & dosage* / Q000494:pharmacology; D008168:Lung / Q000382:microbiology; D051379:Mice; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification / Q000502:physiology*; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin